Below are the most recent publications written about "Benzimidazoles" by people in Profiles.
-
Srour AM, El-Bayaa MN, Temirak A, Alanzy AL, Awad HM, Saleh A, Saleh MG, El-Sayed WA. New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors. Sci Rep. 2025 Jul 15; 15(1):25514.
-
Kodishala RK, Sayyad K, Kowtharapu LP, Konduru N, Mondal T, Varkolu M, Gundekari S. Unspecified degradation impurities identification and characterization in bilastine and montelukast tablet formulations by using UPLC and LCMS/MS: Robustness by design expert and green assessment. Ann Pharm Fr. 2025 Nov; 83(6):1092-1113.
-
Ortiz-Nazario E, Denton-Ortiz CM, Soto-Escobar LDM, Mateo-Mayol Z, Colon-Romero M, Hernandez-Lopez A, Porter JT. Sex-dependent effects of angiotensin II type 1 receptor blocker on molecular and behavioral changes induced by single prolonged stress. Behav Brain Res. 2023 10 02; 454:114639.
-
Jacob J, Steel A, Lin Z, Berger F, Z?eller K, Jarvi S. Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies. Clin Infect Dis. 2022 04 09; 74(7):1293-1302.
-
Gandotra C, Clark J, Liu Q, Senatore FF, Rose M, Zhang J, Stockbridge NL. Heart Failure Population with Therapeutic Response to Sacubitril/Valsartan, Spironolactone and Candesartan: FDA Perspective. Ther Innov Regul Sci. 2022 01; 56(1):4-7.
-
Sutar Y, Fulton SR, Paul S, Altamirano S, Mhatre S, Saeed H, Patel P, Mallick S, Bhat R, Patravale VB, Chauhan H, Nielsen K, Date AA. Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and in Vitro Activity against Cryptococcus neoformans. ACS Infect Dis. 2021 09 10; 7(9):2637-2649.
-
Najar MA, Aravind A, Dagamajalu S, Sidransky D, Ashktorab H, Smoot DT, Gowda H, Prasad TSK, Modi PK, Chatterjee A. Hyperactivation of MEK/ERK pathway by Ca2+ /calmodulin-dependent protein kinase kinase 2?promotes cellular proliferation by activating cyclin-dependent kinases?and minichromosome maintenance protein?in gastric cancer cells. Mol Carcinog. 2021 11; 60(11):769-783.
-
Lu Y, Li M, Lee GY, Zhao N, Chen Z, Edwards A, Zhang K. Seeking the exclusive binding region of phenylalkylamine derivatives on human T-type calcium channels via homology modeling and molecular dynamics simulation approach. Pharmacol Res Perspect. 2021 05; 9(3):e00783.
-
Kashyap VK, Dan N, Chauhan N, Wang Q, Setua S, Nagesh PKB, Malik S, Batra V, Yallapu MM, Miller DD, Li W, Hafeez BB, Jaggi M, Chauhan SC. VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway. Cancer Lett. 2020 02 01; 470:64-74.
-
Mondal T, Nautiyal A, Agrawal M, Mitra D, Goel A, Kumar Dey S. 18F-FDG-induced DNA damage, chromosomal aberrations, and toxicity in V79 lung fibroblast cells. Mutat Res Genet Toxicol Environ Mutagen. 2019 Nov; 847:503105.